Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis

Zhenjie Wu,Qi Chen,Le Qu,Mingmin Li,Linhui Wang,Maria C. Mir,Umberto Carbonara,Savio D. Pandolfo,Peter C. Black,Asit K Paul,Giuseppe Di Lorenzo,Francesco Porpiglia,Andrea Mari,Andrea Necchi,Morgan Rouprêt,Sarah P. Psutka,Riccardo Autorino

European Urology（2022）

引用 32|浏览13

暂无评分

摘要

A high proportion of patients with urologic cancers experience immune checkpoint inhibitor (ICI)-associated toxicity. Physician and patient education is critical for early recognition and proper management.

查看译文

关键词

Immune checkpoint inhibitors,Immunotherapy,Adverse events,Trials,Urology,Renal cell carcinoma,Urothelial carcinoma,Bladder,Renal pelvis,Ureter,Prostate cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要